Large-scale experimental validation of phenotype-guided generative AI for de novo drug discovery
Jure Fabjan, Joanna M. Wenda, Claire Pecoraro-Mercier…·David Rouquié
The paper validates a generative AI model using experimental assays to design small molecule drugs targeting specific cancer-related phenotypes, showing 88% morphological impact and 37% transcriptomic pathway effects.